<DOC>
	<DOCNO>NCT01994369</DOCNO>
	<brief_summary>Breast cancer common cancer second cause cancer mortality woman . There approximately 200,000 new case breast cancer year . Classically , breast cancer divide two group , invasive non-invasive . A mainstay treatment type surgical resection therapeutic purpose also diagnostic purpose . Breast conserve therapy include surgical lumpectomy post-operative radiation . However , despite best surgical practice , patient undergo BCT anywhere 20 - 40 % patient margin positive cancer . This lead increase rate reoperation quote high 30 % increase local recurrence . There expression folate receptor locate surface many human carcinoma nodules.Specifically breast cancer 33 % breast cancer express folate receptor . Folate-fluorescein isothiocyanate , folate-FITC , also identify EC-17 , target folate receptor express certain cancer breast cancer , could help good identifying margin cancer thereby achieve negative margin .</brief_summary>
	<brief_title>Intraoperative Imagery Breast Cancer With Folate-FITC ( EC17 )</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<criteria>1 . Adult patient 18 year age old 2 . Patients present breast cancer presume resectable lumpectomy and/or mastectomy preoperative assessment 3 . Good operative candidate 4 . Subject capable give informed consent participate process consent . 1 . Pregnant woman determine urinary serum beta hCG within 72 hour surgery 2 . Patients history anaphylactic reaction FolateFITC insects 3 . Atrisk patient population 1 . `` People would easily lose follow ( ex : People homeless alcohol dependent ) 2 . Patients unable participate consent process ( child neonates ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Breast Cancer</keyword>
</DOC>